Novo CEO pressed by Senate to chop costs of weight problems, diabetes medicine CEO Lars Fruergaard Jørgensen instructed lawmakers the company would take into account new talks with insurers in regards to the list selling prices of Wegovy and copyright should they pledge to keep the medicines on their own https://daveshotchickencalories49483.mdkblog.com/36387990/the-smart-trick-of-healthcare-news-that-nobody-is-discussing